Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1988 1
1989 1
1990 1
1991 3
1992 2
1993 5
1994 9
1995 2
1996 5
1997 5
1998 9
1999 4
2000 2
2001 1
2002 2
2003 2
2004 1
2005 3
2006 2
2008 3
2009 3
2010 13
2011 5
2012 6
2013 7
2014 9
2015 5
2016 6
2017 8
2018 7
2019 6
2020 1
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

131 results
Results by year
Filters applied: . Clear all
Page 1
Synthetic therapeutic peptides: science and market.
Vlieghe P, Lisowski V, Martinez J, Khrestchatisky M. Vlieghe P, et al. Drug Discov Today. 2010 Jan;15(1-2):40-56. doi: 10.1016/j.drudis.2009.10.009. Epub 2009 Oct 30. Drug Discov Today. 2010. PMID: 19879957 Review.
Proamyloidogenic effects of membrane type 1 matrix metalloproteinase involve MMP-2 and BACE-1 activities, and the modulation of APP trafficking.
Paumier JM, Py NA, García-González L, Bernard A, Stephan D, Louis L, Checler F, Khrestchatisky M, Baranger K, Rivera S. Paumier JM, et al. FASEB J. 2019 Feb;33(2):2910-2927. doi: 10.1096/fj.201801076R. Epub 2018 Oct 17. FASEB J. 2019. PMID: 30332299
., Gonzalez, L. G., Bernard, A., Stephan, D., Louis, L., Checler, F., Khrestchatisky, M., Baranger, K., Rivera, S. Proamyloidogenic effects of membrane type 1 matrix metalloproteinase involve MMP-2 and BACE-1 activities, and the modulation of APP trafficking....
., Gonzalez, L. G., Bernard, A., Stephan, D., Louis, L., Checler, F., Khrestchatisky, M., Baranger, K., Rivera, S. Proamyloidogenic e …
Use of LDL receptor-targeting peptide vectors for in vitro and in vivo cargo transport across the blood-brain barrier.
Molino Y, David M, Varini K, Jabès F, Gaudin N, Fortoul A, Bakloul K, Masse M, Bernard A, Drobecq L, Lécorché P, Temsamani J, Jacquot G, Khrestchatisky M. Molino Y, et al. FASEB J. 2017 May;31(5):1807-1827. doi: 10.1096/fj.201600827R. Epub 2017 Jan 20. FASEB J. 2017. PMID: 28108572
., Drobecq, L., Lecorche, P., Temsamani, J., Jacquot, G., Khrestchatisky, M. Use of LDL receptor-targeting peptide vectors for in vitro and in vivo cargo transport across the blood-brain barrier....
., Drobecq, L., Lecorche, P., Temsamani, J., Jacquot, G., Khrestchatisky, M. Use of LDL receptor-targeting peptide vectors for in vit …
Endogenous and synthetic MMP inhibitors in CNS physiopathology.
Baranger K, Rivera S, Liechti FD, Grandgirard D, Bigas J, Seco J, Tarrago T, Leib SL, Khrestchatisky M. Baranger K, et al. Prog Brain Res. 2014;214:313-51. doi: 10.1016/B978-0-444-63486-3.00014-1. Prog Brain Res. 2014. PMID: 25410364 Review.
Target engagement and intracellular delivery of mono- and bivalent LDL receptor-binding peptide-cargo conjugates: Implications for the rational design of new targeted drug therapies.
Varini K, Lécorché P, Sonnette R, Gassiot F, Broc B, Godard M, David M, Faucon A, Abouzid K, Ferracci G, Temsamani J, Khrestchatisky M, Jacquot G. Varini K, et al. J Control Release. 2019 Nov 28;314:141-161. doi: 10.1016/j.jconrel.2019.10.033. Epub 2019 Oct 20. J Control Release. 2019. PMID: 31644939
131 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page